Johnnie Walker Black Label got cheaper in India this week. Scotch prices in parts of the country have fallen 10–15% since the India–UK trade pact cut the import duty on Scotch whisky from 150% to 75%.

The reflex trade is to sell Indian whisky: cheaper imported Scotch eats the premium end of the market from the top down.

The filings say close to the opposite. India's largest domestic whisky makers aren't primarily Scotch's competitors — they are Scotch's customers, importing it in bulk by the hundreds of crores to blend into their own premium Indian whiskies. For them, a 75-percentage-point duty cut is an input cost cut.

Radico Khaitan: told you it was a tailwind, in writing

Radico Khaitan (RADICO) is the clearest case, and said so the morning after the deal news broke. Its Q4 FY2025 earnings call opened with the FTA, before results:

"For Radico Khaitan, the potential reduction in import duties on Scotch whisky is particularly significant, as we are among the largest importers of bulk Scotch for blending purposes. In FY2026 alone, our Scotch imports are projected to exceed ₹250 crore at landed cost."

That bulk Scotch goes into Sangam, Royal Ranthambore, After Dark and 8PM Premium Black. By the Q1 FY26 call the cut was confirmed — "duty on bulk scotch has been reduced from 150% to 75%" — and asked whether state excise would claw the benefit back, management's conclusion was blunt: "it is a net positive for Radico."

The sell-side had it backwards: on that same call, an analyst asked about "the headwind that we have right now in terms of the UK FTA deal." Management disagreed, and explained why cheaper imported bottles don't threaten them:

"The reduction of price by BIO brand really does not affect us so much because now brands from Radico are being positioned at prices higher than market leader, even higher than scotch whiskeys… Royal Ranthambore is a burning example."

Radico has guided to an EBITDA margin of around 20% for full-year FY2027; Q1 FY27 total IMFL volume was 10 million cases, up 3% year-on-year.

Radico also reckons the cut is worth only a "small benefit of 6% to 8%" at the consumer level for imported brands, and that those companies "are likely to mop up this saving and save on their costs rather" than pass it on. If so, the cut shows up industry-wide as margin, not a price war.

Tilaknagar Industries: the sleeper

Tilaknagar (TI) is the name nobody connects to this story, because TI has always been a brandy company — India's largest Prestige & Above brandy player, past 10 million brandy cases in FY26. Then on 30 November 2025 it completed the acquisition of the Imperial Blue business from Pernod Ricard India for ₹3,442 crore. Imperial Blue is a Scotch-blended Indian whisky. That one deal turned TI into a bulk-Scotch importer.

TI's investor deck now lists the FTA as a line item in its Imperial Blue synergy plan, alongside packaging, bottling and overheads:

"Customs: Reduction in custom under India-UK FTA from 150% to 75% for scotch import. Cost savings will result in 225 – 350 bps in margin expansion on the acquired business."

Elsewhere the deck calls the FTA "a major tailwind leading to potentially expanded EBITDA margins for the IB business division." Be precise: the 225–350 bps is guided for the whole basket of cost savings, not customs alone. But customs is on the list, and it's the one item the government just delivered free.

Scale, from TI's filings: FY26 volumes rose 68% overall, and 14% ex-Imperial Blue to 13.6 million cases. Q3 FY26 EBITDA was ₹90 crore at a 14.0% margin.

Allied Blenders: says it plainly

Allied Blenders and Distillers (ABDL) built Sterling Reserve — a millionaire brand past 5 million cases — on "a unique blend of Scotch malts and Indian grain spirits," and its luxury arm ABD Maestro sells both bottled-in-origin blended Scotch and bottled-in-India blended malt Scotch. Its external-environment slide reads:

"UK FTA: Expected to enhance margins while strengthening the premium and luxury portfolio through greater sourcing flexibility."

ABDL's FY25 EBITDA was ₹451 crore at a 12.7% margin, up from 7.5% in FY24 — a company early in a margin recovery, now handed a cheaper input.

The one that gets no input relief: Piccadily Agro

Piccadily Agro (PICCADIL) owns Indri, India's breakout single malt. On the lazy reading it's the obvious winner from "Indian malt beats Scotch." On the filings it's the one company here that gets no duty benefit. Management was explicit:

"We are not net importers of a lot of bulk scotch, so for our products we mature our products within the country. So that materially doesn't make a lot of difference to us."

Piccadily competes with Scotch on the shelf rather than buying it as an input, so it takes the price competition without the cost offset. It isn't defenceless — IMFL volumes (Indri, Camikara, Cashmir, Whistler) grew 48% in FY26, and it is building a distillery at Portavadie, Scotland, likely commissioning in FY27. But that payoff runs through owning Scottish capacity in 2027+, not an FY27 margin line.

What could go wrong

Import duty is a central lever; alcohol pricing is a state subject. An industry body has already asked states to withdraw concessions for imported Scotch, and state excise departments can re-tax part of the benefit away — the exact risk Radico was questioned on. And if importers cut shelf prices harder than Radico expects, the premium Indian segment sees more competition and less margin than the filings assume.

What retail investors should do

Don't trade the headline's direction. "Scotch cheaper" is not "Indian whisky weaker" — for Radico, Tilaknagar and Allied Blenders it is a disclosed input-cost tailwind each has named in its own filings. The checkable question for the next two quarters is narrow: does gross margin actually expand at the companies that import bulk Scotch? Radico has handed you a number to hold it to (~20% FY27 EBITDA margin), Tilaknagar one for Imperial Blue (225–350 bps). Watch gross margin and realisation per case in Q2 and Q3 FY27 filings, and watch state excise notifications for clawbacks. If margins don't move, the thesis is wrong — and the filings will show it.

Data sourced from company filings on NSE via Xaro.